Muhammad Nazim Farooq1, Aqsa Mehmood2, Fatima Amjad3, Jaweria Syed4. 1. Muhammad Nazim Farooq, PhD. Islamabad College of Physiotherapy, Margalla Institute of Health Sciences Rawalpindi, Rawalpindi, Pakistan. 2. Aqsa Mehmood, DPT Islamabad College of Physiotherapy, Margalla Institute of Health Sciences Rawalpindi, Rawalpindi, Pakistan. 3. Fatima Amjad, DPT Islamabad College of Physiotherapy, Margalla Institute of Health Sciences Rawalpindi, Rawalpindi, Pakistan. 4. Jaweria Syed, MS-SPT Shifa Tameer-e-Millat University, Islamabad, Pakistan.
Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia. It may be either due to decline/absence of production of insulin by pancreas or when pancreas produces enough insulin but the body cannot utilize it or due to both.1 DM is a major health problem touching alarming level. The number of people with DM has been increased by 62% during the last decade worldwide.2 Globally 463 million people were estimated to have DM in 2019.2 The Pakistan was at fourth number among the top ten countries having highest number of people with DM. The diabetic population is continuously increasing in Pakistan.3 where 19.4 million people were estimated to have DM in 2019 which will rise to 26.2 million in 2030 and 37.1 million in 2045.2 Type-1 DM accounts for about 5–15% of all diabetes cases.4 It results from an autoimmune destruction of insulin-producing β cells. The prevalence and incidence of type-1 DM are increasing in the world.4 Subjects with type-1 DM had three times more mortality risk compared to the general population.5 The lifetime cost of a single patient with type-1 DM was estimated to be about USD 0.5 million.6The long-term effects of uncontrolled DM are associated with many clinical problems. DM affects whole body systems and causes significant alterations in peri-articular and musculoskeletal system.7 Though musculoskeletal impairments are common in patients with DM but they have not been well recognized compared to cardiovascular complications.7Shoulder pain is one of the prevailing complains among the diverse musculoskeletal diseases caused by DM.8 DM promotes the thickening of the joint capsule, causing adhesion of the humerus head to the glenohumeral cavity, the main cause of which is unknown. It has been reported that hyperglycemia may result in arthrofibrosis by speeding up glycation and irregular deposition of collagen in the connective tissues surrounding the joints.7 DM causes pain and limited joint mobility of one or both shoulders. It mitigates quality of life, and it also predisposes patients to have disability in daily activities.7-9Earlier studies have shown high prevalence of shoulder disorders in patients having DM compared to controls.7,10-13 For example in a meta-analysis by Zreik et al.10 patients with DM were found to have five times more adhesive capsulitis than controls. Gutefeldt et al.11 reported 2-4 times more shoulder pain and stiffness in patients with DM than controls. Similarly, Raje et al.12 in their article concluded that diabetic patients had more shoulder pain and functional disability (SPFD) compared to controls. However, the majority of the formerly conducted studies included patients diagnosed with both types of DM or most commonly Type-2 of diabetes. Furthermore, most of the published studies, including Type-1 DM, have been conducted in US, Europe, and Australia and there is paucity of data in the Asian countries especially in Pakistan. The aim of the current study was to determine the prevalence of SPFD in patients with Type-1 DM and to explore the impact of duration of the disease, age and gender on SPFD.
METHODS
A cross-sectional survey was conducted on previously diagnosed patients with Type-1 DM between April 2019 and March 2020. Data was collected from six hospitals including three tertiary care hospitals of Islamabad and Rawalpindi. The study was approved by the ethical review committee of Margalla Institute of Health Sciences Rawalpindi (Ref. No. AM/60/19, dated April 30, 2019). Three hundred and twenty-eight patients with 18 to 35 years of age and who were diagnosed with Type-1 DM were included in the study through convenience sampling technique. Patients with recent accident or trauma of shoulder joint, inflammatory arthropathy, bone and nerve pathologies, who were comatose or mentally ill and those whose occupation included repetitive shoulder activities were excluded. All the patients provided a written informed consent.Data was collected by using demographic sheet and Shoulder Pain and Disability Index (SPADI). SPADI is a 13-items questionnaire designed to evaluate SPFD.14,15 It consists of two subscales, pain having 5 items and disability having 8 items. Each item score varies from 0 to 10. The total scores of SPADI ranges from 0 to 100. The higher scores indicate greater impairments. SPADI has shown good psychometric properties.14,15
Sample size
Using 95% confidence interval, 5% error of measurement and prevalence rate of 30.57% reported by an earlier study,16 327 participants were required.
Data Analysis
Data analysis was performed using SPSS v.21. Mean and percentages were calculated to describe the results. Point-biserial and Pearson correlation coefficients were calculated to find out the correlation between the variables. Independent t-test was used to determine difference in the SPADI mean scores between the female and male patients. Five percent significance level was used for all tests.
RESULTS
Three hundred and twenty-eight questionnaires were distributed to Type-1 diabetic patients. All of these were returned. Participants characteristics are shown in Table-I.
Table-I
Participants Characteristics (N = 328).
Variables
Mean
Standard deviation
Age (Years)
29.45
± 5.10
Duration of Diabetes (Years)
7.74
± 5.26
Frequency
Percentage
Gender
Males
127
38.72%
Females
201
61.28%
Hypertension
57
17.38%
Cardiovascular disease
10
3.05%
Generalized body pain
87
26.52%
Eye sight weakness
15
4.57%
Tingling/Numbness
34
10.36%
Polyuria
14
4.27%
Fatigue
16
4.88%
Participants Characteristics (N = 328).Out of 328 Type-1 diabetic patients, 281 (85.7%) patients were affected by SPFD. The mean SPADI score was 40.28±23.15. The SPFD was found significantly correlated to age, duration of the disease and gender (Table-II). It showed that increasing age and greater duration of the disease increases the SPFD.
Table-II
Association of the shoulder pain and disability to age, duration of diabetes mellitus and gender.
Variables
Shoulder pain and disability
r
P-value
Age (years)
0.332
< 0.001
Duration of Diabetes Mellitus (years)
0.154
0.005
Gender
0.171
0.002
Association of the shoulder pain and disability to age, duration of diabetes mellitus and gender.A significant difference was found in the SPADI mean scores between female and male patients (female patients = 43.42±22.80, male patients = 35.31±22.91, p = 0.002). The results showed that female is at more risk for developing SPFD.
DISCUSSION
This study highlights significantly high prevalence of SPFD in patients with Type-1 DM. This finding is consistent with the outcomes of earlier studies.17,18 However, it is slightly higher compared to the findings of Shah et al. and Ahmad et al.19,20 The prevalence rate of SPFD in the current study also varies with the findings of the other studies (24.9 – 41.3%).16,21-23 This might be due to the reason that in the current study the prevalence was reported about symptoms i.e., pain and disability rather than specific diagnosis (e.g., adhesive capsulitis) reported by these studies.A recent study in Sweden reported shoulder pain and stiffness in 44% and 49% of diabetic patients respectively.24 The difference may be due to the questionnaires used for collecting data. In the Swedish study the data was collected by asking a single question about each pain and stiffness i.e., “do you have pain/stiffness in your shoulder joint”. Where as in the current study, the data was collected by using a reliable and valid questionnaire called SPADI which explored pain and disability by asking 13 different questions about these symptoms while performing different functional activities.A significant correlation was found between SPFD and age of the patients. This was in line with the results of previous studies which further strengthens the notion that pain and disability at shoulder joint increases with increasing age in patients with Type-1 DM.16,22,25 The present study also found a significant correlation between SPFD and duration of DM. Previous studies results were comparable to these findings.11,12,16,22,25 It reflects that as the duration of DM increase shoulder pain disability increases as well.The present study found that females with Type-1 DM were substantially associated with increased pain and disability at shoulder joint than males which is consistent with the findings of earlier studies.11,16,18,20,23As the number of patients with Type-1 DM will increase, it is likely that shoulder pain and disability will become the most common complaint in these patients visiting diabetic clinics. Therefore, it would be more appropriate to include musculoskeletal examination of shoulder joint in the routine screening procedures in patients having Type-1 DM to prevent functional disability.
Limitations of the study
As the study design was cross sectional therefore cannot give casual answers about underlying mechanism and determine changes over time. The results of current study cannot be generalized to a larger population due to small sample size.
CONCLUSION
The prevalence of SPFD was found substantially high in Type-1 diabetic patients. Increasing age, longer duration of DM and female gender have significant association with pain and disability of shoulder joint. These findings suggest that there is a need to focus on periodical musculoskeletal examination of shoulder during follow-up and to develop strategies for rehabilitation in patients with Type-1 DM both for clinicians and researchers.
Authors’ Contribution:
MNF: Concept, design, literature review, analysis and interpretation of data, writing of manuscript, critical revision of the article for important intellectual content. Responsible and accountable for the accuracy or integrity of the work.AM: Concept, design, literature review, data collection, data analysis, writing of manuscript.FA: Literature review, analysis and interpretation of data, writing of manuscript.JS: Concept, design, data collection, writing of manuscript.All authors have read and approved the manuscript.
Authors: Kristine Bech Holte; Niels Gunnar Juel; Jens Ivar Brox; Kristian Folkvord Hanssen; Dag Sigurd Fosmark; David R Sell; Vincent M Monnier; Tore Julsrud Berg Journal: J Diabetes Complications Date: 2017-06-22 Impact factor: 2.852
Authors: Pouya Saeedi; Inga Petersohn; Paraskevi Salpea; Belma Malanda; Suvi Karuranga; Nigel Unwin; Stephen Colagiuri; Leonor Guariguata; Ayesha A Motala; Katherine Ogurtsova; Jonathan E Shaw; Dominic Bright; Rhys Williams Journal: Diabetes Res Clin Pract Date: 2019-09-10 Impact factor: 5.602
Authors: Eileen Morgan; Catherine R Black; Noina Abid; Christopher R Cardwell; David R McCance; Christopher C Patterson Journal: Pediatr Diabetes Date: 2017-05-26 Impact factor: 4.866
Authors: Kerstin Gutefeldt; Simon Lundstedt; Ingrid S M Thyberg; Margareta Bachrach-Lindström; Hans J Arnqvist; Anna Spångeus Journal: J Diabetes Res Date: 2020-03-11 Impact factor: 4.011
Authors: Mary E Larkin; Annette Barnie; Barbara H Braffett; Patricia A Cleary; Lisa Diminick; Judy Harth; Patricia Gatcomb; Ellen Golden; Janie Lipps; Gayle Lorenzi; Carol Mahony; David M Nathan Journal: Diabetes Care Date: 2014-04-10 Impact factor: 19.112